00.covid19:210816_抗体依存性感染増強ade
差分
このページの2つのバージョン間の差分を表示します。
| 最新のリビジョン両方とも次のリビジョン | |||
| 00.covid19:210816_抗体依存性感染増強ade [2021/08/16] – 作成 adash333 | 00.covid19:210816_抗体依存性感染増強ade [2021/08/21] – [見出し] adash333 | ||
|---|---|---|---|
| 行 4: | 行 4: | ||
| ===== 見出し ===== | ===== 見出し ===== | ||
| + | |||
| + | |||
| + | https:// | ||
| + | Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination? | ||
| + | Nouara Yahi | ||
| + | Published: | ||
| + | |||
| + | |||
| + | |||
| + | |||
| + | |||
| + | |||
| + | |||
| + | |||
| + | |||
| + | |||
| + | |||
| + | |||
| https:// | https:// | ||
00.covid19/210816_抗体依存性感染増強ade.txt · 最終更新: 2021/08/21 by adash333